Paul Acton

928 total citations
9 papers, 753 citations indexed

About

Paul Acton is a scholar working on Physiology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Paul Acton has authored 9 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 3 papers in Pharmacology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Paul Acton's work include Alzheimer's disease research and treatments (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). Paul Acton is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). Paul Acton collaborates with scholars based in United States and Brazil. Paul Acton's co-authors include Taihung Duong, Paul J. Shughrue, Gene G. Kinney, Maria Nikolaeva, Jasna Jerecı̀ć, Diana Wu, Eileen H. Bigio, Fernanda G. De Felice, Pauline T. Velasco and William L. Klein and has published in prestigious journals such as Biochemistry, Brain Research and Pain.

In The Last Decade

Paul Acton

9 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Acton United States	8	605	243	177	151	147	9	753
Jasna Jerecı̀ć United States	11	673 1.1×	406 1.7×	242 1.4×	162 1.1×	233 1.6×	18	985
David Beaulieu‐Abdelahad United States	19	424 0.7×	408 1.7×	205 1.2×	213 1.4×	173 1.2×	31	1.0k
Virginie Buggia-Prévot United States	14	660 1.1×	407 1.7×	154 0.9×	217 1.4×	244 1.7×	19	1.0k
Shengjun Chang United States	6	590 1.0×	376 1.5×	133 0.8×	147 1.0×	205 1.4×	8	851
Kevin Atchison United States	10	445 0.7×	368 1.5×	164 0.9×	94 0.6×	194 1.3×	19	854
Marta Rodrı́guez Spain	8	408 0.7×	249 1.0×	143 0.8×	119 0.8×	174 1.2×	9	732
Ashley N. Nilson United States	3	616 1.0×	325 1.3×	145 0.8×	216 1.4×	111 0.8×	9	810
Ricardo Albay United States	11	619 1.0×	289 1.2×	107 0.6×	310 2.1×	148 1.0×	14	833
Rebekah Patton United States	9	606 1.0×	200 0.8×	111 0.6×	191 1.3×	86 0.6×	12	734
Bruno Vasconcelos Belgium	7	632 1.0×	342 1.4×	100 0.6×	201 1.3×	185 1.3×	8	772

Countries citing papers authored by Paul Acton

Since Specialization

Citations

This map shows the geographic impact of Paul Acton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Acton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Acton more than expected).

Fields of papers citing papers by Paul Acton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Acton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Acton. The network helps show where Paul Acton may publish in the future.

Co-authorship network of co-authors of Paul Acton

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Acton. A scholar is included among the top collaborators of Paul Acton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Acton. Paul Acton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Lightfoot, Yaíma L., Kendra Allton, Jiacheng Ma, et al.. (2023). RIP Kinase 1 (RIPK1) modulates disease associated microglial response during demyelination. Alzheimer s & Dementia. 19(S21). 1 indexed citations

Ma, Jiacheng, Paul Acton, Virginie Buggia-Prévot, et al.. (2021). Inhibition of dual leucine zipper kinase prevents chemotherapy-induced peripheral neuropathy and cognitive impairments. Pain. 162(10). 2599–2612. 16 indexed citations

Fernandez, Celia, Paul Acton, Virginie Buggia-Prévot, et al.. (2020). Dual Leucine Zipper Kinase Is Constitutively Active in the Adult Mouse Brain and Has Both Stress-Induced and Homeostatic Functions. International Journal of Molecular Sciences. 21(14). 4849–4849. 10 indexed citations

Kesler, Shelli R., Paul Acton, Vikram R. Rao, & William J. Ray. (2018). Functional and structural connectome properties in the 5XFAD transgenic mouse model of Alzheimer’s disease. Network Neuroscience. 2(2). 241–258. 22 indexed citations

Shughrue, Paul J., Paul Acton, Robert Breese, et al.. (2008). Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons. Neurobiology of Aging. 31(2). 189–202. 37 indexed citations

Felice, Fernanda G. De, Diana Wu, Mary P. Lambert, et al.. (2007). Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers. Neurobiology of Aging. 29(9). 1334–1347. 349 indexed citations

Hepler, Robert W., Karen M. Grimm, Deborah D. Nahas, et al.. (2006). Solution State Characterization of Amyloid β-Derived Diffusible Ligands. Biochemistry. 45(51). 15157–15167. 162 indexed citations

Duong, Taihung, et al.. (1998). The in vitro neuronal toxicity of pentraxins associated with Alzheimer's disease brain lesions. Brain Research. 813(2). 303–312. 42 indexed citations

Duong, Taihung, Maria Nikolaeva, & Paul Acton. (1997). C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease. Brain Research. 749(1). 152–156. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact